Literature DB >> 12729675

Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches.

Robert A Pearlstein1, Roy J Vaz, Jiesheng Kang, Xiao-Liang Chen, Maria Preobrazhenskaya, Andrey E Shchekotikhin, Alexander M Korolev, Ludmila N Lysenkova, Olga V Miroshnikova, James Hendrix, David Rampe.   

Abstract

A data set consisting of twenty-two sertindole analogues and ten structurally diverse inhibitors, spanning a wide range in potency, was analyzed using CoMSiA. A homology model of HERG was constructed from the crystal structure of the open MthK potassium channel. A complementary relationship between our CoMSiA and homology models is apparent when the long inhibitor axis is oriented parallel to the longitudinal axis of the pore, with the tail region pointed toward the selectivity filter. The key elements of the pharmacophore, the CoMSiA and the homology model are: (1) The hydrophobic feature optimally consists of an aromatic group that is capable of engaging in pi-stacking with a Phe656 side chain. Optionally, a second aromatic or hydrophobic group present in some inhibitors may contact an additional Phe656 side chain. (2) The basic nitrogen appears to undergo a pi-cation interaction with Tyr652. (3) The pore diameter (12A+), and depth of the selectivity loop relative to the intracellular opening, act as constraints on the conformation-dependent inhibitor dimensions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729675     DOI: 10.1016/s0960-894x(03)00196-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

1.  Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay.

Authors:  Hai-bo Yu; Bei-yan Zou; Xiao-liang Wang; Min Li
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

2.  3D-QSAR illusions.

Authors:  Arthur M Doweyko
Journal:  J Comput Aided Mol Des       Date:  2004 Jul-Sep       Impact factor: 3.686

3.  Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data.

Authors:  Claire L Gavaghan; Catrin Hasselgren Arnby; Niklas Blomberg; Gert Strandlund; Scott Boyer
Journal:  J Comput Aided Mol Des       Date:  2007-03-24       Impact factor: 3.686

4.  Computer-aided drug design: the next 20 years.

Authors:  John H Van Drie
Journal:  J Comput Aided Mol Des       Date:  2007-11-08       Impact factor: 3.686

5.  Interactions of H562 in the S5 helix with T618 and S621 in the pore helix are important determinants of hERG1 potassium channel structure and function.

Authors:  James P Lees-Miller; Julia O Subbotina; Jiqing Guo; Vladimir Yarov-Yarovoy; Sergei Y Noskov; Henry J Duff
Journal:  Biophys J       Date:  2009-05-06       Impact factor: 4.033

6.  Shape signatures: new descriptors for predicting cardiotoxicity in silico.

Authors:  Dmitriy S Chekmarev; Vladyslav Kholodovych; Konstantin V Balakin; Yan Ivanenkov; Sean Ekins; William J Welsh
Journal:  Chem Res Toxicol       Date:  2008-05-08       Impact factor: 3.739

7.  Cardio-vascular safety beyond hERG: in silico modelling of a guinea pig right atrium assay.

Authors:  Luca A Fenu; Ard Teisman; Stefan S De Buck; Vikash K Sinha; Ron A H J Gilissen; Marjoleen J M A Nijsen; Claire E Mackie; Wendy E Sanderson
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

8.  Compilation and physicochemical classification analysis of a diverse hERG inhibition database.

Authors:  Remigijus Didziapetris; Kiril Lanevskij
Journal:  J Comput Aided Mol Des       Date:  2016-10-25       Impact factor: 3.686

9.  Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.

Authors:  Claudia Kiesecker; Edgar Zitron; Sonja Lück; Ramona Bloehs; Eberhard P Scholz; Sven Kathöfer; Dierk Thomas; Volker A W Kreye; Hugo A Katus; Wolfgang Schoels; Christoph A Karle; Johann Kiehn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-30       Impact factor: 3.000

10.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.